Trials / Completed
CompletedNCT03700047
GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 270 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GAL1704 | new dermal filler |
| DEVICE | Juvederm Voluma | hyaluronic acid |
Timeline
- Start date
- 2018-10-18
- Primary completion
- 2019-06-10
- Completion
- 2020-05-22
- First posted
- 2018-10-09
- Last updated
- 2022-08-26
- Results posted
- 2022-05-31
Locations
15 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03700047. Inclusion in this directory is not an endorsement.